ScholarLens Back to search
2020•The Medical Journal of AustraliaRequires access

Providing take home naloxone needs to be improved to prevent opioid overdose deaths

Nicholas Lintzeris

Open publisher page 3 citations

Abstract

I have sat on advisory boards for Mundipharma, Camurus, and Indivior, have received research funding from Camurus, and provided consultancy services for Mundipharma.

About this research paper

What this paper is about

I have sat on advisory boards for Mundipharma, Camurus, and Indivior, have received research funding from Camurus, and provided consultancy services for Mundipharma.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

I have sat on advisory boards for Mundipharma, Camurus, and Indivior, have received research funding from Camurus, and provided consultancy services for Mundipharma.

Key concepts: (+)-Naloxone, Opioid overdose, Medicine, Opioid, Medical emergency, Anesthesia, Internal medicine, Receptor

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Providing take home naloxone needs to be improved to prevent opioid overdose deaths — Research Paper | ScholarLens